Original Research
Accepted on 04 Feb 2025
Designing Novel Cabozantinib Analogues as p-glycoprotein Inhibitors to Target Cancer Cell Resistance using Molecular Docking Study, ADMET Screening, Bioisosteric Approach, and Molecular Dynamics Simulations
in Medicinal and Pharmaceutical Chemistry